Chemomab Therapeutics (CMMB) PT Lowered to $11 at Oppenheimer

November 15, 2024 8:10 AM EST Send to a Friend

Oppenheimer analyst Jeff Jones lowered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Chemomab Therapeutics (CMMB) PT Lowered to $11 at Oppenheimer

Member Login

Free News Feed